Are you interested in medical images and image analysis? Would you like to work in a growing company devoted to making a real difference in drug development through ground-breaking imaging? A company, where you would contribute and be a part of a collaborative team? If this ticks your boxes, you should continue reading.
At Antaros Medical, we are pioneering imaging methodologies, such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), to design and deliver clinical studies for decision making and differentiation in drug development.
We value competence and development as well as ideas and solutions. Relations and trust are keys to success, and it is equally important for us to have fun while doing a meaningful job. We have currently around 130 employees working at our offices in Mölndal, Uppsala and Lund, and we are continuously growing and developing.
As a part of our growth journey, we are looking for an analytical and detail-focused Image Analyst to join our team in Uppsala.
As an Image Analyst, you will be responsible for quality control and segmentation of medical images from MR and PET investigations in a technical and research-intensive environment. You will work in a team that together analyse and deliver data for clinical trials using tools to segment organs and structures in the medical images. Your responsibility also includes communication with national and international imaging centres. You do not need any previous experience from image analysis and will, as part of your on-boarding, receive a mentor and undergo an extensive training programme.

DESIRED QUALIFICATIONS AND SKILLS:

• High school grade, preferably in natural science, possibly any relevant higher education, for example as a biomedical analyst or in healthcare (or equivalent or similar skills gained through work experience), higher education is not a requirement
• Computer proficiency
• Good knowledge of spoken and written English

• Quality control of images and related documentation from the MR and PET investigations in the clinical trials
• Segmentation of images from the MR and PET investigations including documentation of this
• Communication with national and international imaging centres on image quality